title: 35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy.
authors.forename: N D
authors.initials: ND
authors.lastname: Mehta
authors.forename: A L
authors.initials: AL
authors.lastname: Hooberman
authors.forename: E E
authors.initials: EE
authors.lastname: Vokes
authors.forename: S
authors.initials: S
authors.lastname: Neeley
authors.forename: S
authors.initials: S
authors.lastname: Cotler
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*
chemical_list: D016898:Interferon-alpha